Neurosurgery
In Reply: Novel Urokinase-Type Plasminogen Activator Receptor-Targeting Optical Imaging Agent ICG-Glu-Glu-AE105 for Visualization of Malignant Glioma During Surgery: First-in-Human Study in 35 Patients With Brain Cancer.
Jane Skjøth-Rasmussen, Andreas Kjaer
Published: 202510.1227/neu.0000000000003805
No abstract available for this study.